Human plasma derived antithrombin clinical trials

Phase 3 Study on the Efficacy and Safety of Human Plasma Derived Antithrombin (Atenativ) in Heparin-Resistant Patients Scheduled to Undergo Cardiac Surgery Necessitating Cardiopulmonary Bypass

This study looks at a medicine called Atenativ for people having heart surgery who don't respond well to standard blood thinners. It checks if Atenativ helps their blood thin properly and if it's safe to use.